Remove 2010 Remove Clinical Trials Remove Consumption
article thumbnail

Project CBD Responds to the FDA’s 2023 Statement on CBD

Project CBD

But as for nonpharmaceutical CBD — the FDA insists it’s too risky for public consumption. It’s worth noting that cannabidiol (CBD), as a whole plant option or derivative has been available since 2010, and millions of people have used CBD products without apparent harm.

CBD 130
article thumbnail

Best strains and terpenes for pain management

The Cannigma

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. Managing pain with cannabis may require a multi-faceted approach, where you use an oral consumption method like capsules on a daily basis, and topical products or smoking as needed. And this is an area of ample scientific research.

Terpenes 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cannabinoids for Tinnitus?

Project CBD

Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.

article thumbnail

Mixing weed and alcohol: the good, the bad and the ugly

The Cannigma

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. A 2010 study found that consuming alcohol “slightly prolonged” the half-life of THC in the blood.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. YANINA PEPINO, PHD COURTNEY D.

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

The authors share this view, assessing that the current evidence shows that marijuana can impair driving ability and increase crash risk, especially shortly after consumption. Marijuana Decriminalization, Medical Marijuana Laws, and Fatal Traffic Crashes in US Cities, 2010–2017. A meta-analysis by Asbridge et al. Accident Anal Prev.

Policy 59
article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

In 2010, another pre-clinical study was also conducted on mice, and published in the American Journal of Hospice and Palliative Care. All these findings correlate with the conclusions of the scientists who were involved in the mice study from 2010.

Strains 94